ConductScience.org, home

Paper39624342

Ultrasound-targeted sirolimus-loaded microbubbles improves acute rejection of heart transplantation in rats by inhibiting TGF-β1-Smad signaling pathway, promoting autophagy and reducing inflammation.

Bao H and 3 others. Int J Pharm X, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Ultrasound-targeted sirolimus-loaded microbubbles improves acute rejection of heart transplantation in rats by inhibiting TGF-β1-Smad signaling pathway, promoting autophagy and reducing inflammation. Papers, record 39624342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39624342

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ultrasound-targeted sirolimus-loaded microbubbles improves acute rejection of heart transplantation in rats by inhibiting TGF-β1-Smad signaling pathway, promoting autophagy and reducing inflammation.
PubMed
Journal
Int J Pharm X
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.36, provisional
iCite
Revised in PubMed
2024-12-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bao HHaiwei
2Dai LLulu
3Wang HHuiyang
4Jiang TTianan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129493571Transplantation: Sirolimus after heart transplantation.Nat Rev Cardiol2018https://conductscience.org/library/papers/29493571PubMed
233717174Artemisinin Attenuates Transplant Rejection by Inhibiting Multiple Lymphocytes and Prolongs Cardiac Allograft Survival.Front Immunol2021https://conductscience.org/library/papers/33717174PubMed
320185042Ultrasound-microbubble-mediated intercellular adhesion molecule-1 small interfering ribonucleic acid transfection attenuates neointimal formation after arterial injury in mice.J Am Coll Cardiol2010https://conductscience.org/library/papers/20185042PubMed
437477064Tacrolimus population pharmacokinetics in adult heart transplant patients.Br J Clin Pharmacol2023https://conductscience.org/library/papers/37477064PubMed
534157419Acute allograft rejection after heart transplantation: Outcomes of admissions and 30-day re-admissions.Hellenic J Cardiol2022https://conductscience.org/library/papers/34157419PubMed
637495292Heart Transplantation: Indications, Surgical Techniques, and Complications.Radiol Clin North Am2023https://conductscience.org/library/papers/37495292PubMed
733976108Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy.Cell Death Dis2021https://conductscience.org/library/papers/33976108PubMed
833462174Sirolimus Adverse Event Profile in a Non-Clinical Trial Cohort of Heart Transplantation Patients.Ann Transplant2021https://conductscience.org/library/papers/33462174PubMed
930317990Preparation of Cationic Lipid-coated Ultrasound Contrast Agents and Noninvasive Gene Transfection Via Ultrasound-targeted Microbubble Destruction.Curr Pharm Des2018https://conductscience.org/library/papers/30317990PubMed
1032305482Cardiac Magnetic Resonance Parametric Mapping Following Heart Transplantation: Moving Beyond Acute Rejection and Coronary Allograft Vasculopathy Assessment.JACC Cardiovasc Imaging2020https://conductscience.org/library/papers/32305482PubMed
1134942327Highlights in ultrasound-targeted microbubble destruction-mediated gene/drug delivery strategy for treatment of malignancies.Int J Pharm2022https://conductscience.org/library/papers/34942327PubMed
1238102643Ultrasound-targeted microbubble destruction promotes PDGF-primed bone mesenchymal stem cell transplantation for myocardial protection in acute Myocardial Infarction in rats.J Nanobiotechnology2023https://conductscience.org/library/papers/38102643PubMed
1336463323Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect.Br J Cancer2023https://conductscience.org/library/papers/36463323PubMed
1433480423Negative regulators of TGF-β1 signaling in renal fibrosis; pathological mechanisms and novel therapeutic opportunities.Clin Sci (Lond)2021https://conductscience.org/library/papers/33480423PubMed
1533325244Impact of Sirolimus as a Primary Immunosuppressant on Myocardial Fibrosis and Diastolic Function Following Heart Transplantation.J Am Heart Assoc2021https://conductscience.org/library/papers/33325244PubMed
1631820529Assessment of rejection risk following subtherapeutic calcineurin inhibitor levels after pediatric heart transplantation.Pediatr Transplant2020https://conductscience.org/library/papers/31820529PubMed
1734662671Ultrasonic particles: An approach for targeted gene delivery.Adv Drug Deliv Rev2021https://conductscience.org/library/papers/34662671PubMed
1831448528mTOR inhibitors vs calcineurin inhibitors: A Catch-22-preventing nephrotoxicity or acute allograft rejection after heart transplantation.Am J Transplant2019https://conductscience.org/library/papers/31448528PubMed
1932828538Ultrasound targeted microbubble destruction assisted exosomal delivery of miR-21 protects the heart from chemotherapy associated cardiotoxicity.Biochem Biophys Res Commun2020https://conductscience.org/library/papers/32828538PubMed
2033066828Quercetin regulates fibrogenic responses of endometrial stromal cell by upregulating miR-145 and inhibiting the TGF-β1/Smad2/Smad3 pathway.Acta Histochem2020https://conductscience.org/library/papers/33066828PubMed

See all 32 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
41472729Acoustic immune reprogramming: a novel paradigm for spatiotemporally controlled immune regulation using ultrasound-responsive nanoplatforms.Front Immunol2025https://conductscience.org/library/papers/41472729PubMed
40959490Ultrasound-targeted microbubble destruction: a prospective strategy for treating cardiovascular disease.Front Cardiovasc Med2025https://conductscience.org/library/papers/40959490PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39624342

GET https://conductscience.org/api/papers/v1/39624342/references?page=2